August 22, 2008 — Concomitant zoledronic acid (Zometa, Novartis) that is given during adjuvant endocrine therapy can prevent bone loss in premenopausal breast cancer patients. It also improves ...

A recent study by the University of Eastern Finland is the first to report that the fatty acid composition of blood and the enzyme activity associated with it predict the development of bone mineral ...

New research reveals that oleic acid, abundant in olive oil, protects aging mice from gum infection-induced bone loss and gut microbiome disruption, highlighting how what we eat may help prevent ...

SEATTLE — Among bariatric surgery patients treated with denosumab to counter bone loss, follow-up treatment with zoledronic acid prevented the rebound effect on markers of bone turnover that is ...